Gilad Sorek
Auburn University
48 Papers
52 Citations
Gilad Sorek is an academic researcher from Auburn University. The author has contributed to research in topics: Medicine & Competition (economics). The author has an hindex of 4, co-authored 32 publications. Previous affiliations of Gilad Sorek include State University of New York System & University at Buffalo.
Chat about Author
Papers
Migration costs, commuting costs and intercity population sorting
TL;DR: In this paper, the effects of reducing intercity commuting time on urbanization process from Suburb to Metropolis is studied. And it is shown that reducing commuting time can moderate, stop, or reverse the migration process.
28
Patents and quality growth in OLG economy
TL;DR: In this article, the authors study a close Overlapping generations economy that grows through sequential quality improvements and show that for plausible values of the Inter-temporal Elasticity of Substitution, shorter patent length enhances growth and under exogenous innovation size loosening patent breadth protection spurs R&D investment and quality growth.
24
Autonomic cardiac control response to walking and executive cognitive task in adolescents with acquired brain injury and typically developed controls
TL;DR: Adding a cognitive task to a walking task can improve the CACS function of ABI adolescents, while ABI adolescent’s response to a cognitive demand during an activity task such as walking was similar to the response of TD adolescents.
9
Piracy, Imitation, and Optimal Copyright Policy
TL;DR: In this article, the authors present a model of optimal copyright policy which incorporates several realistic features which have hitherto been largely ignored, and the mutual recognition of these two features leads to some surprising conclusions relevant to current debate over copyright reform.
7
Competition and Product Choice in Option Demand Markets
TL;DR: In this article, the authors present the first analysis of competition through horizontal and vertical differentiation in option demand markets, which are common in the health care sector, and show that product choices in such markets differ greatly from those in respective spot markets and bundling medical products under a single insurance policy alters product choices and equilibrium prices in a way that does not benefit consumers.